⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TTRX News
Turn Therapeutics Inc. Common Stock
Form 8-K
sec.gov
TTRX
Turn Therapeutics to Present at Jefferies Global Healthcare Conference 2026
businesswire.com
TTRX
Form 8-K
sec.gov
TTRX
Turn Therapeutics Appoints Physician-Scientist and Former FDA Commissioner, Dr. Stephen M. Hahn, as Executive Clinical and Regulatory Lead
businesswire.com
TTRX
Form 8-K
sec.gov
TTRX
Turn Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Updates
businesswire.com
TTRX
Form 8-K
sec.gov
TTRX
Turn Therapeutics Reports Full Year 2025 Financial Results and Provides Corporate Updates
businesswire.com
TTRX
Form 8-K
sec.gov
TTRX
Turn Therapeutics to Present at Upcoming TD Cowen and Oppenheimer Healthcare Conferences
businesswire.com
TTRX